These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The use of the 2 substituted 5-nitroimidazole, Fexinidazole (Hoe 239) in the treatment of chronic T. brucei infections in mice. Jennings FW, Urquhart GM. Z Parasitenkd; 1983; 69(5):577-81. PubMed ID: 6636983 [Abstract] [Full Text] [Related]
14. Chemotherapy of Trypanosoma brucei in mice with diminazene aceturate. Variation in the aparasitaemic period over 5 years. Jennings FW, Gray GD, Whitelaw DD. Z Parasitenkd; 1982; 67(3):337-40. PubMed ID: 6127848 [No Abstract] [Full Text] [Related]
16. Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Congo. Priotto G, Kasparian S, Ngouama D, Ghorashian S, Arnold U, Ghabri S, Karunakara U. Clin Infect Dis; 2007 Dec 01; 45(11):1435-42. PubMed ID: 17990225 [Abstract] [Full Text] [Related]
17. Experimental infection with two stocks of Trypanosoma brucei gambiense. Study of the evolution by elution techniques of tissues. Mulumba PM, Wéry M. Contrib Microbiol Immunol; 1983 Dec 01; 7():120-9. PubMed ID: 6825435 [No Abstract] [Full Text] [Related]
18. NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness. Yun O, Priotto G, Tong J, Flevaud L, Chappuis F. PLoS Negl Trop Dis; 2010 May 25; 4(5):e720. PubMed ID: 20520803 [No Abstract] [Full Text] [Related]